Shared care - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

Shared care

When clinical, and therefore prescribing, responsibility for a patient is transferred from hospital to GP, it is of the utmost importance that the GP has full confidence to prescribe the necessary drugs. It is, therefore, essential that a transfer involving drug therapies with which GPs would not normally be familiar should not take place without full local agreement and the dissemination of sufficient information to individual GPs.
When a consultant considers a patient's condition is stable, he may seek the agreement of the GP concerned to share care. In proposing a shared care arrangement, a consultant may advise the general practitioner which medicine to prescribe. Where a new, or rarely prescribed, medicine is being recommended, its dosage and administration must be specified by the consultant so that the GP is properly informed and can monitor treatment and adjust the dose if necessary. In addition, when a treatment is not licensed for a particular indication, then full justification for the use of the drug should be given by the consultant to the GP.

Walford D. Responsibility for prescribing between hospitals and GPs
NHS Executive Circular. EL (91) 127, November 1991

Documents

Purple
ATOMOXETINE
Date Posted: 08 - Jun - 2018
Body System: Nervous system
Purple
ATOMOXETINE for the treatment of ADHD in Adults
Date Posted: 31 - Jan - 2018
Body System: Nervous system
Purple
Atypical antipsychotics
Date Posted: 24 - Sep - 2014
Body System: Nervous system
Purple
AZATHIOPRINE
Date Posted: 27 - Sep - 2017
Body System: Blood and blood-forming organs Gastro-intestinal system Musculoskeletal system Skin
Purple
Azathioprine and mercaptopurine for the treatment of inflammatory bowel disease
Date Posted: 01 - Sep - 2011
Body System: Gastro-intestinal system
Purple
CICLOSPORIN
Date Posted: 08 - Jun - 2018
Body System: Genito-urinary system Musculoskeletal system Nervous system Respiratory system Skin
Purple
DAPSONE for dermatology indications
Date Posted: 26 - Apr - 2018
Body System: Skin
Purple
DEXAMFETAMINE
Date Posted: 30 - Nov - 2016
Body System: Nervous system
Purple
DEXAMFETAMINE for the treatment of ADHD in Adults
Date Posted: 31 - Jan - 2018
Body System: Nervous system
Purple
GUANFACINE
Date Posted: 30 - Nov - 2016
Body System: Nervous system
Purple
Inflammatory arthropathies, drug treatment of
Date Posted: 01 - Dec - 2008
Body System: Musculoskeletal system
Purple
LEFLUNOMIDE
Date Posted: 27 - Sep - 2017
Body System: Musculoskeletal system Respiratory system Skin
Purple
LISDEXAMFETAMINE
Date Posted: 30 - Nov - 2016
Body System: Nervous system
Purple
Lithium treatment in adults
Date Posted: 05 - Nov - 2018
Body System: Nervous system
Purple
MERCAPTOPURINE
Date Posted: 14 - Aug - 2018
Body System: Gastro-intestinal system Musculoskeletal system
Purple
METHOTREXATE
Date Posted: 01 - Nov - 2018
Body System: Gastro-intestinal system Musculoskeletal system Nervous system Respiratory system Skin
Purple
METHYLPHENIDATE
Date Posted: 30 - Nov - 2016
Body System: Nervous system
Purple
METHYLPHENIDATE for the treatment of ADHD in Adults
Date Posted: 31 - Jan - 2018
Body System: Nervous system
Purple
MYCOPHENOLATE MOFETIL
Date Posted: 08 - Jun - 2018
Body System: Gastro-intestinal system Genito-urinary system Musculoskeletal system Nervous system Skin
Purple
PENICILLAMINE
Date Posted: 08 - Jun - 2018
Body System: Gastro-intestinal system Musculoskeletal system
Purple
Rheumatology, drug treatment of inflammatory conditions
Date Posted: 01 - Jun - 2014
Body System: Musculoskeletal system
Purple
RILUZOLE
Date Posted: 27 - Sep - 2017
Body System: Nervous system
Purple
SODIUM AUROTHIOMALATE
Date Posted: 14 - Aug - 2018
Body System: Musculoskeletal system
Purple
SULFASALAZINE
Date Posted: 14 - Aug - 2018
Body System: Gastro-intestinal system Musculoskeletal system